investors

With a rapidly growing business in Europe and plans for a future launch in the US, Sedana Medical is well-positioned for the future.

We are well on the way to our vision of making inhaled sedation a standard therapy in critical care.

The Share

Press Releases

2026

2026-10-22 07:00
Regulatory
FDA review under way and sales growth returns Third quarter 2026 January-September 2026 CEO comments FDA review under way and sales growth returns The...
2026-10-15 07:00
Sedana Medical AB (publ) plans to present its interim report for the third quarter of 2026 on Thursday, October 22, 2026, at 13:30 CET. According to the...
2026-10-14 17:30
Regulatory
According to the principles for the appointment of the Nomination Committee in Sedana Medical AB (publ), the Nomination Committee for the Annual General...

Financial Reports

Financial Calendar

Latest Presentation

No presentations found.